These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 8752188
1. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group. Podrid PJ, Anderson JL. Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188 [Abstract] [Full Text] [Related]
2. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias. Rae AP. Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902 [Abstract] [Full Text] [Related]
3. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M, Cullen MT, Casadei G. Eur Heart J; 1995 Dec 16; 16(12):1943-51. PubMed ID: 8682031 [Abstract] [Full Text] [Related]
4. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]
5. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F. Ann Cardiol Angeiol (Paris); 1996 Oct 25; 45(8):469-79. PubMed ID: 8952741 [Abstract] [Full Text] [Related]
6. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group. Aliot E, Denjoy I. Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394 [Abstract] [Full Text] [Related]
7. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356 [Abstract] [Full Text] [Related]
8. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study]. Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R. G Ital Cardiol; 1996 Apr 01; 26(4):379-90. PubMed ID: 8707022 [Abstract] [Full Text] [Related]
9. Clinical experience with propafenone for cardiac arrhythmias in the young. Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M. Eur Heart J; 1994 Aug 01; 15(8):1050-6. PubMed ID: 7527342 [Abstract] [Full Text] [Related]
10. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists. Janousek J, Paul T. Am J Cardiol; 1998 May 01; 81(9):1121-4. PubMed ID: 9605053 [Abstract] [Full Text] [Related]
11. [Efficacy of propafenone in supraventricular arrhythmias]. Kauffmann R, Goich J, Parra C, Ayala A, Manzur F. Rev Med Chil; 1989 Apr 01; 117(4):401-5. PubMed ID: 2519393 [Abstract] [Full Text] [Related]
12. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia]. Honerjäger P, Schmidt G. Z Gesamte Inn Med; 1993 Sep 01; 48(9):425-9. PubMed ID: 8212747 [Abstract] [Full Text] [Related]
13. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. Coumel P, Leclercq JF, Assayag P. Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770 [Abstract] [Full Text] [Related]
14. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation]. Mihálcz A, Földesi C, Kardos A, Ladunga K, Szili-Török T. Orv Hetil; 2009 Sep 06; 150(36):1694-700. PubMed ID: 19709984 [Abstract] [Full Text] [Related]
15. The Wrong Drug That Led to the Right Diagnosis. Bergonti M, Assanelli E, Agostoni P. Circulation; 2019 Nov 05; 140(19):1601-1604. PubMed ID: 31682531 [No Abstract] [Full Text] [Related]
16. Guidelines for the use of propafenone in treating supraventricular arrhythmias. Kishore AG, Camm AJ. Drugs; 1995 Aug 05; 50(2):250-62. PubMed ID: 8521758 [Abstract] [Full Text] [Related]
17. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G. N Engl J Med; 2004 Dec 02; 351(23):2384-91. PubMed ID: 15575054 [Abstract] [Full Text] [Related]
18. [Use of propafenone in emergency therapy]. Liguori A, Pellegrino G, Di Ieso N, Piatto A, Ruggiero P, Scarnera P, Guardascione A. Clin Ter; 1989 Dec 15; 131(5):307-14. PubMed ID: 2532584 [Abstract] [Full Text] [Related]
19. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD. Congenit Heart Dis; 2014 Dec 15; 9(3):221-7. PubMed ID: 23947935 [Abstract] [Full Text] [Related]
20. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Luedtke SA, Kuhn RJ, McCaffrey FM. Ann Pharmacother; 1997 Nov 15; 31(11):1347-59. PubMed ID: 9391691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]